|
Clinical properties
|
Total
|
p53 expression (n/%)
|
|---|
|
Negative (%)
|
Positive (%)
|
P value
|
|---|
|
Gender
|
|
Male
|
106
|
10(52.6 %)
|
96(66.7 %)
|
0.228
|
|
Female
|
57
|
9(47.4 %)
|
48(33.3 %)
|
|
Age (mean)
|
|
< 58
|
82
|
7(36.8 %)
|
75(53.6 %)
|
0.171
|
|
≥ 58
|
77
|
12(63.2 %)
|
65(46.4 %)
|
|
Histopathological gradea
|
|
Well
|
40
|
8(42.1 %)
|
32(22.9 %)
|
0.070
|
|
Moderate
|
98
|
8(42.1 %)
|
91(65.0 %)
|
|
Poor
|
20
|
3(15.8 %)
|
17(12.1 %)
|
|
Invasion depth
|
|
T1-T2
|
76
|
8(47.1 %)
|
68(51.1 %)
|
0.752
|
|
T3-T4
|
74
|
9(52.9 %)
|
65(48.9 %)
|
|
Lymphatic invasion
|
|
N0
|
68
|
6(33.3 %)
|
62(49.2 %)
|
0.207
|
|
N1-N3
|
76
|
12(66.7 %)
|
64(50.8 %)
|
|
TNM Staging
|
|
I/II
|
79
|
9(60.0 %)
|
70(64.2 %)
|
0.750
|
|
III/IV
|
45
|
6(40.0 %)
|
39(35.8 %)
|
|
HPV infection
|
|
Negative
|
67
|
4(28.6 %)
|
63(57.8 %)
|
0.039
|
|
Positive
|
56
|
10(71.4 %)
|
46(42.2 %)
|
-
P < 0.05 indicates a significant association among the variables
-
a Well differentiation vs. moderate + poor differentiation
